產(chǎn)品描述: | MOMIPP,一種巨胞飲作用的誘導(dǎo)劑,是一種 PIKfyve 抑制劑。MOMIPP 可穿過血腦屏障 (BBB)。 |
靶點: |
PI3K |
體外研究: |
MOMIPP can induce intense macropinocytosis, leading to methuosis in cultured glioblastoma cells at low micromolar concentrations[1]. In U373 and Hs683 cell lines, 3 μM for MOMIPP induces cell vacuolization. MOMIPP (10?μM) causes early disruptions of glucose uptake and glycolytic metabolism. MOMIPP selectively activates the JNK1/2 stress kinase pathway, resulting in phosphorylation of c-Jun, Bcl-2 and Bcl-xL. |
體內(nèi)研究: |
MOMIPP (80?mg/kg; i.p.; once daily; for 15 consecutive days) shows moderately effective in suppressing progression of intracerebral glioblastoma xenografts. |
參考文獻: |
1.Margaux Colin, et al. Dysregulation of Macropinocytosis Processes in Glioblastomas May Be Exploited to Increase Intracellular Anti-Cancer Drug Levels: The Example of Temozolomide. Cancers (Basel). 2019 Mar 22;11(3):411.
2.Zehui Li, et al. The JNK signaling pathway plays a key role in methuosis (non-apoptotic cell death) induced by MOMIPP in glioblastoma. BMC Cancer. 2019 Jan 16;19(1):77. |
保存條件: |
-20℃ |
配置溶液濃度參考: |
|
1mg |
5mg |
10mg |
1 mM |
3.421 ml |
17.104 ml |
34.208 ml |
5 mM |
0.684 ml |
3.421 ml |
6.842 ml |
10 mM |
0.342 ml |
1.71 ml |
3.421 ml |
50 mM |
0.068 ml |
0.342 ml |
0.684 ml |
|
注意: |
部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。 |